E-LIB Suche - Ergebnisse für: Scherl, E

1

DOP35 Spatial transcriptomics reveals cellular niches assoc..:

Battat, R ; Sangiorgi, B ; Linggi, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i135-i136 , 2024

Link: https://doi.org/10.1093/..

2

P704 Safety of Immunosuppression in A Prospective Cohort of..:

Axelrad, J ; Jiang, Y ; Colombel, J F...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1329-i1329 , 2024

Link: https://doi.org/10.1093/..

3

OP15 Efficacy of ustekinumab for Ulcerative Colitis through..:

Danese, S ; Afif, W ; Abreu, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i19-i20 , 2023

Link: https://doi.org/10.1093/..

4

P912 Increased Primary Bile Acids with Ileocolonic Resectio..:

Battat, R ; Scherl, E ; Lukin, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i1025-i1025 , 2023

Link: https://doi.org/10.1093/..

5

P382 Serum Ustekinumab Concentrations are Associated with I..:

Chen, K ; Chen, J ; Smith, E...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i517-i517 , 2023

Link: https://doi.org/10.1093/..

6

P245 The Relationship Between the Endoscopic Healing Index ..:

Smith, E ; Chen, J ; Pan, Y...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i396-i397 , 2023

Link: https://doi.org/10.1093/..

7

P377 Impact of moderate-to-severe endoscopic disease criter..:

Allez, M ; Lewis, J D ; Hanauer, S B...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i379-i380 , 2022

Link: https://doi.org/10.1093/..

8

Joint Disease Activity in Inflammatory Bowel Disease–associ..:

Lai, D. ; Funez-dePagnier, G. ; Duenas-Bianchi, L....
Gastro Hep Advances. 1 (2022) 2 - p. 137-140 , 2022

Link: https://doi.org/10.1016/..

9

P508 Dose adjustment in patients with moderate to severe ul..:

Rowbotham, D S ; Scherl, E J ; Sands, B E...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S488-S489 , 2021

Link: https://doi.org/10.1093/..

10

DOP76 No durable impact of COVID-19 on disease activity and..:

Funez-dePagnier, G ; Lima, S ; Duenas-Bianchi, L...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S109-S110 , 2021

Link: https://doi.org/10.1093/..

11

OP02 Ustekinumab versus adalimumab for induction and mainte..:

Irving, P M ; Sands, B E ; Hoops, T...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S001-S002 , 2021

Link: https://doi.org/10.1093/..

12

DOP86 Corticosteroid-sparing effects of ustekinumab therapy..:

Scherl, E J ; Rowbotham, D S ; Danese, S...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S117-S118 , 2021

Link: https://doi.org/10.1093/..

13

DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Col..:

Abreu, M T ; Danese, S ; Sandborn, W J...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S113-S115 , 2021

Link: https://doi.org/10.1093/..

14

OP40 A core transferable microbiota in responders to faecal..:

Gogokhia, L ; Lima, S ; Viladomiu, M...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S040-S041 , 2020

Link: https://doi.org/10.1093/..

15

P729 The SAPPHIRE registry: Safety of immunosuppression in ..:

Axelrad, J ; Colombel, J F ; Scherl, E...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S585-S587 , 2020

Link: https://doi.org/10.1093/..